secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2022-04-18T23:59:59+00:00
Accession:  0001493152-22-010231
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Marc Bregman resigns effective April 29, 2022; search underway
------------------------------------------------------------------

- Marc Bregman notified his resignation as CFO, Treasurer, Secretary, and Principal Financial and Accounting Officer.
- His last day with the company will be April 29, 2022; he leaves to pursue another opportunity.
- The company has commenced a search for a replacement; no successor has been named.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315222010231/0001493152-22-010231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315222010231/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-010231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer